Delivery Order SPE2DB22D9239-SPE2DB25FDL57
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $30,127.56 by the Defense Logistics Agency (DLA) on August 18, 2025. The contract calls for the delivery of EXPAREL (liposomal bupivacaine) 266 mg/20 ml vials, a long-acting local anesthetic commonly used in surgical and post-operative pain management. This firm fixed-price delivery order, with an ultimate completion date of September 9,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $12,053.55 by the Defense Logistics Agency (DLA) on September 24, 2025. The contract calls for the delivery of Exparel 266 mg/20 ml vials, a liposomal bupivacaine product used for infiltration and nerve block anesthesia in surgical settings. The delivery order is set to be completed by October 16, 2025, with performance...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $30,127.56 by the Defense Logistics Agency on August 20, 2025. The contract calls for the delivery of Exparel 266 mg/20 ml vials, a liposomal bupivacaine formulation used for post-operative pain management. The award carries no set-aside designation, and performance is scheduled for completion by September 11, 2025, with...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $42,185.32 by the Defense Logistics Agency (DLA) on September 12, 2025. The order covers the supply of EXPAREL 266 mg/20 ml vials, a liposomal bupivacaine product used for local anesthesia and pain management in surgical and medical applications. This is a firm fixed-price delivery order with no set-aside designation, reflecting the company's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,655.32 by the Defense Logistics Agency on August 28, 2025. The contract covers the delivery of Exparel 133 mg/10 ml vials, a liposomal bupivacaine product used for local anesthesia and postoperative pain management. Performance of this delivery order is scheduled for completion by September 19, 2025, with the place of...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $30,127.56 on July 14, 2025, by the Defense Logistics Agency's Medical Supply Chain. The contract covers the supply of EXPAREL 266 mg/20 ml vials, a liposomal bupivacaine local anesthetic used in surgical and post-operative pain management. The delivery order is firm fixed price with an ultimate completion date of August 4, 2025, and...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on June 2, 2025, with a ceiling value of $20,085.04. The contract calls for the delivery of EXPAREL (liposomal bupivacaine) 266 mg/20 mL vials, a long-acting local anesthetic used in surgical and medical settings. The award carries no set-aside designation and is scheduled for ultimate completion...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,770.20 by the Defense Logistics Agency (DLA) on September 5, 2025. The delivery order is for 4,569,416,460 units of EXPAREL 266 mg/20 mL vials, a liposomal bupivacaine product used for post-operative pain management. The contract carries an ultimate completion date of September 26, 2025, and includes no set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $25,106.30 firm fixed-price delivery order by the Defense Logistics Agency on August 14, 2025, for the supply of EXPAREL (liposomal bupivacaine) 266 mg/20 mL vials. The contract carries an ultimate completion date of September 5, 2025, and involves no set-aside designation. This delivery order represents a continuation of DMS Pharmaceutical Group's substantial role...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,021.26 by the Defense Logistics Agency (DLA) on July 22, 2025. The delivery order is for EXPAREL 266 mg/20 mL vials, a liposomal bupivacaine product used for post-operative pain management. The contract carries no set-aside designation and requires ultimate completion by August 12, 2025, with performance to be executed...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB25FDL57Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $52,649.48 by the Defense Logistics Agency on September 5, 2025. The contract calls for the delivery of Exparel 266 mg/20 ml vials, a liposomal bupivacaine local anesthetic commonly used for surgical pain management. The delivery order is not set-aside designated and carries an ultimate completion date of September 26, 2025, with performance to be executed in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products supporting medical supply needs across Department of Defense healthcare facilities worldwide. As a consistent supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages its woman-owned small business status to compete effectively in federal procurement markets while providing critical prescription medications, biologics, and medical consumables to military health facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $52.6k | 9/5/25 |